Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

A ribozyme that cuts DNA - programmably!! It has a ways to go before it can be a precision genome editing tool - short target recognition sequence, doesn’t bind dsDNA well - but an exciting discovery nonetheless! Study from Jun-Jie Gogo Liu lab at Tsinghua University, published in Science Magazine

41,549 Aufrufe • vor 2 Jahren •via X (Twitter)

1 Kommentare

Profilbild von Julia Bauman
Julia Baumanvor 2 Jahren

& the link:

Ähnliche Videos

Demis Hassabis just described the moment medicine stops treating disease and starts deleting it from the source code. For all of human history, doctors have fought symptoms. The tumor. The organ failure. The collapse. Always downstream. Always after the damage has already started. The cause sits upstream. Written into the DNA. Ninety-eight percent of the human genome sits in non-coding regions. For decades, science understood the genes but couldn’t read the vast dark territory between them. That’s where most disease hides. Hassabis: “It takes the big, long genetic sequences and then it tries to predict, if you made a mutation to this particular single letter, single position in the genetic sequence, will that be a harmful mutation that might cause disease, or is it benign?” AlphaGenome reads your entire genetic sequence and identifies the exact letter that’s corrupted. Not a region. Not a probability range. A single position in a three-billion-letter sequence. That alone would be a generational breakthrough. But most diseases aren’t that clean. Hassabis: “What if they’re multigenic diseases where there’s cascades of mutations causing the problem? Those are even harder to detect, but actually perfect for sort of AI.” One mutation is hard enough to find. A cascade of mutations interacting across the genome is a problem no human researcher can hold in their head at once. Three billion data points. Compounding errors across all of them. The human brain cannot solve that. AI doesn’t solve it either. It maps it. All of it. At once. The most devastating diseases on Earth. The ones medicine has called untreatable for generations. They are not mysteries to the algorithm. They’re compute problems. But finding the error was only ever half the equation. You also need the ability to fix it. That tool already exists. CRISPR is a molecular scalpel. It cuts DNA at exact positions. The limitation was never the editing. It was knowing exactly where to cut. Hassabis: “A kind of combination of things like AlphaGenome and CRISPR could be incredibly powerful.” AI reads the code. CRISPR rewrites it. One finds the mutation. The other corrects it at the source. Not managing symptoms. Not slowing progression. Deleting the error from the genome. The implications go beyond treatment. A disease corrected at the genetic level doesn’t just disappear from one patient. It disappears from their bloodline. The read access is here. The write access exists. The merge is inevitable. The era of accepting a broken genetic hand is ending. We stopped being passengers in our own biology.

Dustin

197,790 Aufrufe • vor 3 Monaten

REMINDER: The genome for SARS-CoV-2 is a "consensus sequence." Anybody who says the gene sequence for SARS2 is confirmed is *confused or lying.* "[The reality is that] nobody has the code of the pathogen..." "What they set for the control [for the PCR 'test'] is a consensus sequence, which [means] they took AI, they averaged out a section of the genome that they want as that test, and they set it for that. So it doesn't even exist in nature anywhere." This is a clip from a recent discussion between former medical coder and whistleblower Zowe Smith (Sheldon Diedericks) and retired pharma R&D executive Sasha Latypova (sashalatypova.substack.com "Due Diligence and Art"). Smith and Latypova discuss the many shortcomings of PCR "tests," as well as the fact that no genome for SARS-CoV-2 has ever been characterized—only a "consensus sequence," which Smith notes is developed when AI "average[s] out... a section of the genome that they want as a test." She adds, "it doesn't even exist in nature anywhere." Latypova confirms, "when they're saying, 'Oh, we have the COVID virus, the full genome...it's been sequenced. Look at all these papers.' [The reality is that] nobody has the code of the pathogen... Ralph Baric also wrote about it in his work all the time. So nobody has the pathogenic sequence." The pharma insider adds, "What they upload to GenBank is... averaged... And once it's averaged, it's no longer pathogenic anything. It's just a model. And then for PCR, [it] doesn't test the full genome. They do these, like, snippets, and then whatever snippet you wanna set it to, you will find it, and that's how they find... positive COVID. So all of this is total BS." Interestingly, Smith notes that when she worked with PCR in a lab at the Oregon Health and Science University "[she] realized that everything was controlled through EUA [Emergency Use Authorization] and the CDC, so there was no way to independently verify [the controls that were used]."

Sense Receptor

22,816 Aufrufe • vor 1 Jahr

🚨EPSTEIN FILES STATE THE CREATED NEANDERTHALS CLONES Clones of Neanderthals were created in underground tunnels as stated in the Epstein files released by the DOJ government in 2026. It is impossible to ignore the truth at this point. The truth is stranger than fiction and we have not heard anything stranger than this happening in real life. Per Charlie T Griffen The first studies of Neanderthal DNA focused on the genetic sequences of mitochondria, the microscopic organelles that convert food to energy within cells. In 2005, however, 454 began a collaborative project with the Max Planck Institute in Leipzig, Germany, to sequence the full genetic code of a Neanderthal woman who died in Croatia's Vindija cave 30,000 years ago. As the Neanderthal genome is painstakingly sequenced, the archaeologists and biologists who study it will be faced with an opportunity that seemed like science fiction just 10 years ago. They will be able to look at the genetic blueprint of humankind's nearest relative and understand its biology as intimately as our own. In addition to giving scientists the ability to answer questions about Neanderthals' relationship to our own species--did we interbreed, are we separate species, who was smarter--the Neanderthal genome may be useful in researching medical treatments. Newly developed techniques could make cloning Neanderthal cells or body parts a reality within a few years. The ability to use the genes of extinct hominins is going to force the field of paleoanthropology into some unfamiliar ethical territory. There are still technical obstacles, but soon it could be possible to use that long-extinct genome to safely create a healthy, living Neanderthal clone. Should it be done? At the 454 Life Sciences offices, Gerald Irzyk, Jason Affourtit, and Thomas Jarvie explain the process they use to read the chemicals that made up Neanderthal DNA and the genes that determined a large part of their biology. DNA has a shape, called a double helix, that makes it look like a twisted ladder. Each rung on the ladder is called a base-pair. The rungs are made up of a pair of chemicals called nucleotides--adenine, thymine, cytosine, and guanine, which are usually referred to by their first initials. The sequence of the nucleotides in the DNA determines what genes an organism has and how they function. Max Planck Institute initially chose 454 because it had come up with a way to read hundreds of thousands of DNA sequences at a time. Genome-sequencing technology is advancing at a rate comparable to computer processing power. Putting the fragments themselves in order can be a little tricky. "At first glance, it's just this completely random assemblage of As, Ts, Cs, and Gs," says Irzyk. "But it turns out there are patterns and motifs, and sometimes these are very specific to a group of organisms." For the Neanderthal sample, the human and chimpanzee genomes were used as references for checking the sequence. Working with ancient DNA can be much more problematic than sequencing genetic material from living species. Within hours of death, cells begin to break down in a process called apoptosis. The dying cells release enzymes that chop up DNA into tiny pieces. In a human cell, this means that the entire three-billion-base-pair genome is reduced to fragments a few hundred base-pairs long or shorter. The DNA also goes through chemical changes that alter the nucleotides as it ages--C changes into T, and G turns into A--which can cause the gene sequence to be interpreted incorrectly. In the case of the Neanderthal sample, somewhere between 90 and 99 percent of the DNA came from bacteria and other contaminants that had found their way into the bone as it sat in the ground and in storage. The contaminant DNA has to be identified and eliminated. Given the similarity between Neanderthal and modern human DNA, this can be especially difficult when the contamination comes from the people who excavated or analyzed the bone.

SANTINO

54,154 Aufrufe • vor 5 Monaten